Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Haag

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
International Journal of Cancer|December 1, 2018
Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapyGeorg Martin Haag, Elena Czink, Aysel Ahadova, et al.
Medical Teacher|March 11, 2017
Electronic assessment of clinical reasoning in clerkships: A mixed-methods comparison of long-menu key-feature problems with context-rich single best answer questionsSören Huwendiek, Friedrich Reichert, Cecilia Duncker, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2015
Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische OnkologieSylvie Lorenzen, Jorge Riera Knorrenschild, Georg-Martin Haag, et al.
Frontiers in Oncology|June 25, 2021
<i>Beta-2-microglobulin</i> Mutations Are Linked to a Distinct Metastatic Pattern and a Favorable Outcome in Microsatellite-Unstable Stage IV Gastrointestinal CancersElena Busch, Aysel Ahadova, Kosima Kosmalla, et al.
European Journal of Cancer (Oxford, England : 1990)|April 15, 2022
Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer - The PICCASSO phase I trialGeorg Martin Haag, Christoph Springfeld, Barbara Grün, et al.
British Journal of Cancer|July 3, 2018
Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trialAnne Katrin Berger, Stephan Lücke, Ulrich Abel, et al.
International Journal of Cancer|February 16, 2026
Detection of MSI signals from peripheral blood for monitoring response to immune checkpoint blockade therapy in patients with advanced microsatellite-unstable gastrointestinal cancers: A pilot studyAysel Ahadova, Lena Bohaumilitzky, Thomas Walle, et al.
HLA|October 17, 2022
A simple approach for detecting HLA-A*02 alleles in archival formalin-fixed paraffin-embedded tissue samples and an application example for studying cancer immunoeditingJohannes Witt, Saskia Haupt, Aysel Ahadova, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 12, 2020
Metastatic adult pancreatoblastoma: Multimodal treatment and molecular characterization of a very rare diseaseAnne Katrin Berger, Sadaf Shabbir Mughal, Michael Allgäuer, et al.
Frontiers in Oncology|November 1, 2023
Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma-a phase II trial of the AIO study group (AIO STO 0321)Joseph Tintelnot, Alexander Stein, Salah-Eddin Al-Batran, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
International Journal of Cancer|December 1, 2018
Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapyGeorg Martin Haag, Elena Czink, Aysel Ahadova, et al.
Medical Teacher|March 11, 2017
Electronic assessment of clinical reasoning in clerkships: A mixed-methods comparison of long-menu key-feature problems with context-rich single best answer questionsSören Huwendiek, Friedrich Reichert, Cecilia Duncker, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2015
Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische OnkologieSylvie Lorenzen, Jorge Riera Knorrenschild, Georg-Martin Haag, et al.
Frontiers in Oncology|June 25, 2021
<i>Beta-2-microglobulin</i> Mutations Are Linked to a Distinct Metastatic Pattern and a Favorable Outcome in Microsatellite-Unstable Stage IV Gastrointestinal CancersElena Busch, Aysel Ahadova, Kosima Kosmalla, et al.
European Journal of Cancer (Oxford, England : 1990)|April 15, 2022
Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer - The PICCASSO phase I trialGeorg Martin Haag, Christoph Springfeld, Barbara Grün, et al.
British Journal of Cancer|July 3, 2018
Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trialAnne Katrin Berger, Stephan Lücke, Ulrich Abel, et al.
International Journal of Cancer|February 16, 2026
Detection of MSI signals from peripheral blood for monitoring response to immune checkpoint blockade therapy in patients with advanced microsatellite-unstable gastrointestinal cancers: A pilot studyAysel Ahadova, Lena Bohaumilitzky, Thomas Walle, et al.
HLA|October 17, 2022
A simple approach for detecting HLA-A*02 alleles in archival formalin-fixed paraffin-embedded tissue samples and an application example for studying cancer immunoeditingJohannes Witt, Saskia Haupt, Aysel Ahadova, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 12, 2020
Metastatic adult pancreatoblastoma: Multimodal treatment and molecular characterization of a very rare diseaseAnne Katrin Berger, Sadaf Shabbir Mughal, Michael Allgäuer, et al.
Frontiers in Oncology|November 1, 2023
Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma-a phase II trial of the AIO study group (AIO STO 0321)Joseph Tintelnot, Alexander Stein, Salah-Eddin Al-Batran, et al.
Pageof 8